Ketamine therapy for mental health a ‘wild West’ for doctors and patients

In late 2022, Sarah Gutilla’s treatment-resistant depression had grown so severe, she was actively contemplating suicide.

NCI funds study to investigate the underlying cellular mechanisms that drive ER+ breast cancer

The National Cancer Institute (NCI) has awarded a 5-year, $2.7 million grant to researchers at Sanford Burnham Prebys to investigate and elucidate the underlying cellular

August 7, 2023

Unmasking Fake Acid: The Dangers of 25I-NBOMe Disguised as LSD | Psychedelic Spotlight

In recent times, a concerning trend has emerged in the world of recreational drug use – the proliferation of NBOMes, also known as “fake acid.”

July 21, 2023

Shorla acquires methotrexate solution from Therakind in the US – Pharmaceutical Technology

Shorla raised $35m earlier this month to advance its oncology pipeline. Credit: zorazhuang via Getty Images. Shorla Oncology has acquired the oncology and autoimmune drug

October 31, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.